Radiation as salvage therapy for patients with Hodgkin's disease relapsing after MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy.
Publication
, Journal Article
Diehl, LF; Perry, DJ; Terebelo, H; Baldwin, PE; Hurwitz, M; Kimball, DB; Dorn, RV
Published in: Cancer Treat Rep
September 1983
Six patients with Hodgkin's disease who failed MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy, with recurrences confined to lymph node areas, are reported. All patients were treated with tumoricidal doses of irradiation in mantle, inverted Y, or whole-abdominal fields. All six patients achieved complete remission, with minimal toxicity. Disease-free survival ranged from 3 to 38 months, with four patients remaining in complete remission at 9, 15, 27, and 38 months. Radiation therapy should be considered in patients failing MOPP chemotherapy with lymph node disease.
Duke Scholars
Published In
Cancer Treat Rep
ISSN
0361-5960
Publication Date
September 1983
Volume
67
Issue
9
Start / End Page
827 / 829
Location
United States
Related Subject Headings
- Vincristine
- Procarbazine
- Prednisone
- Mechlorethamine
- Humans
- Hodgkin Disease
- Drug Therapy, Combination
Citation
APA
Chicago
ICMJE
MLA
NLM
Diehl, L. F., Perry, D. J., Terebelo, H., Baldwin, P. E., Hurwitz, M., Kimball, D. B., & Dorn, R. V. (1983). Radiation as salvage therapy for patients with Hodgkin's disease relapsing after MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy. Cancer Treat Rep, 67(9), 827–829.
Diehl, L. F., D. J. Perry, H. Terebelo, P. E. Baldwin, M. Hurwitz, D. B. Kimball, and R. V. Dorn. “Radiation as salvage therapy for patients with Hodgkin's disease relapsing after MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy.” Cancer Treat Rep 67, no. 9 (September 1983): 827–29.
Diehl LF, Perry DJ, Terebelo H, Baldwin PE, Hurwitz M, Kimball DB, et al. Radiation as salvage therapy for patients with Hodgkin's disease relapsing after MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy. Cancer Treat Rep. 1983 Sep;67(9):827–9.
Diehl, L. F., et al. “Radiation as salvage therapy for patients with Hodgkin's disease relapsing after MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy.” Cancer Treat Rep, vol. 67, no. 9, Sept. 1983, pp. 827–29.
Diehl LF, Perry DJ, Terebelo H, Baldwin PE, Hurwitz M, Kimball DB, Dorn RV. Radiation as salvage therapy for patients with Hodgkin's disease relapsing after MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy. Cancer Treat Rep. 1983 Sep;67(9):827–829.
Published In
Cancer Treat Rep
ISSN
0361-5960
Publication Date
September 1983
Volume
67
Issue
9
Start / End Page
827 / 829
Location
United States
Related Subject Headings
- Vincristine
- Procarbazine
- Prednisone
- Mechlorethamine
- Humans
- Hodgkin Disease
- Drug Therapy, Combination